Effect of intraoperative intrapelvic chemotherapy with hyperthermia on the incidence of rectal cancer recurrences

Articles

https://doi.org/10.37469/0507-3758-2014-60-1-64-70

Published 15.12.2014

⁺⁻
⁺⁻
⁺⁻
⁺⁻

State Research Centre of Coloproctology 2Russian Medical Academy of Postgraduate Education

##article.numberofdownloads## 23

##article.numberofviews## 69

PDF (Русский)

Keywords

rectal cancer
intrapelvic cisplatin chemotherapy with hyperthermia
recurrence of rectal cancer

How to Cite

, , , & . (2014). Effect of intraoperative intrapelvic chemotherapy with hyperthermia on the incidence of rectal cancer recurrences. Voprosy Onkologii, 69(5), 64–70. https://doi.org/10.37469/0507-3758-2014-60-1-64-70

Abstract

Often due to a severe somatic condition of the patient, the presence of perifocal inflammation, anemia, age, it is not possible to perform neoadjuvant chemoradiotherapy for rectal cancer. To improve cancer treatment outcomes in these patients intraoperative intrapelvic chemotherapy with hyperthermia is used at the Centre. In the present study there included 120 patients with rectal cancer at stage T3-4N0-2M0, while 60 patients underwent intraoperative intrapelvic chemotherapy with hyperthermia (cisplatin at a dose of 150 mg, the time of the procedure - 60 minutes, the temperature of the perfusate - 44-45 ° C). Conducting of intraoperative intrapelvic chemotherapy with hyperthermia allowed reducing the frequency of local recurrence in 2 times from 16.7% to 8.3% and increasing a 3-year overall survival by 10% - from 63% to 73%, which shows intraoperative intrapelvic chemotherapy with hyperthermia as an effective method in the prevention of local recurrences.

https://doi.org/10.37469/0507-3758-2014-60-1-64-70

##article.numberofdownloads## 23

##article.numberofviews## 69

PDF (Русский)

References

Алексеев М.В., Шелыгин Ю.А., Ревельский И.А., Рыбаков Е.Г. Обоснованность применения интраоперационной внутритазовой химиотерапии в сочетании с гипертермией при лечении рака прямой кишки // Вопр. онкол. - 2011. - Т 57.- С. 173-178.

Воробьев Г.И., Ревельский И.А., Еропкин П.В. и др. Профилактика возникновения рецидивов рака прямой кишки с помощью интраоперационной внутритазовой химиотерапии с гипертермией // Колопроктол. - 2007. - № 3. - С. 3-7.

Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологичекой помощи населению России в 2012 году,- М.: ФГБУ «МНИОИ им. П.А. Герцена Минздрава России», 2013. - 232 с.

Переводчикова Н.И. Руководство по химиотерапии опухолевых заболеваний.- М.: Практическая медицина. - 2005. - 155с.

Arredondo J., Baixauli J., Beorlegui C. et al. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradio-therapy and adjuvant chemotherapy //Dis Colon Rectum.-2013. - Vol. 56. - P. 416-421.

Bonnetain F., Bosset J.F., Gerard J.P et al. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question? // Eur J Cancer. - 2012.- Vol. 48. - P. 1781-1790.

Bujko K., Nowacki M.P., Nasierowska-Guttmejer A. et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer // Br. J. Surg.- 2006.- Vol. 93. - P.1215-1223.

Ceelen W.P., Flessner M.F. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence // Nat. Rev. Clin. Oncol. - 2010. - Vol. 7. - P108-115.

Chan A.K., Wong A., Jenken D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy // Int J Radiat Oncol Biol Phys.- 2005.- Vol. 61.- P665-677.

Enrquez-Navascus J.M., Borda N., Lizerazu A. et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach // World J Gastroenterol. - 2011.-Vol. 17.- P1674-1684.

Fujimoto S., Takahashi M., Endoh F. A clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent the local recurrence of rectal cancer //Ann. Surg.- 1991.- Vol. 213. - P43-47.

Fulk M.H., Issels R.D. Invited Review: Hyperthermia in oncology // Int. J. Hyperthermia.- 2001. - Vol. 17.- P1-19.

Glehen O., Kwiatkowski F., Sugarbaker P.H. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study // J Clin oncol.- 2004.- Vol.22. - P. 3284-3292.

Gunderson L.L., Sargent D.J., Tepper J.E. et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis // J Clin Oncol.-2004.- Vol. 22. - P1785-1796.

Issels R.D. Hyperthermia adds to chemotherapy // Eur. J. Cancer. - 2008.- Vol. 44.- P. 2546-2554.

Jemal A., Siegel R., Ward E. Cancer Statistics // Cancer J. Clin.- 2010. - Vol. 60.- P 277-300.

Kim S.H., Bae K.B., Kim J.M. et al. Oncologic outcomes and risk factors for recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases //J Korean Soc Coloproctol. - 2012. - Vol. 28. - P. 100-107.

Peeters K.C., Marijnen C.A., Nagtegaal I.D. et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma //Ann. Surg - 2007. -Vol. 246. - P. 693-701.

Popek S., Tsikitis V.L. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? // World J. Gastroenterol. - 2011. - Vol. 7. - P. 848-854.

Quirke P, Steele R., Monson J. et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO 16 randomized clinical trial // Lancet. - 2009. - Vol. 373. - P. 821-828.

Sugarbaker P.H., Mora J.T., Carmignani P. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy // Oncologist. - 2005. - Vol. 10. - P. 112-122.

Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer // N Engl J Med. - 1997. - Vol. 336. - P 980-987.

Takahashi M., Fujimoto S., Kobayashi K. Clinical outcome of intraoperative pelvic hyperthermochemotherapy for patients with Dukes’ C rectal cancer // Int J Hyperthermia. - 1994. - Vol. 10. - P749-754.

Takahashi M., Fujimoto S., Takai M. Clinical evaluation of intra-operative pelvic hyperthermochemotherapy combined with operation for rectal cancer // Gan To Kagaku Ryoho.- 1991.- Vol. 18. - P 2024-2027.

Van der Speeten K., Stuart O.A., Sugarbaker P.H. Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy // Curr Drug Discov Technol. - 2009. - Vol. 6. - P. 72-81.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.